Generic name: OSPEMIFENE 60mg
Dosage form: tablet, film coated
Medically reviewed on March 1, 2018.
OSPHENA is an estrogen agonist/antagonist which has agonistic effects on the endometrium. Generally, when a product with estrogen agonistic effects on the endometrium is prescribed for a postmenopausal woman with a uterus, a progestin should be considered to reduce the risk of endometrial cancer. A woman without a uterus does not need a progestin [see Warnings and Precautions (5.2)].
Use of OSPHENA should be for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be re-evaluated periodically as clinically appropriate to determine if treatment is still necessary.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Osphena (ospemifene)
- Osphena Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 17 Reviews
- Drug class: selective estrogen receptor modulators